Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8110
+0.0260 (3.31%)
May 2, 2025, 10:44 AM EDT - Market open

Kairos Pharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Kairos Pharma stock have an average target of 8.33, with a low estimate of 4.00 and a high estimate of 12. The average target predicts an increase of 927.13% from the current stock price of 0.81.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.00 $8.33 $9.00 $12
Change +393.22% +927.13% +1009.7% +1379.7%

Analyst Ratings

The average analyst rating for Kairos Pharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 111233
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111233

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong Buy Maintains $9 +1,009.74% Apr 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$12
Strong Buy Initiates $12 +1,379.65% Apr 3, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong Buy Maintains $9 +1,009.74% Mar 31, 2025
Maxim Group
Maxim Group
Strong Buy
Initiates
$4
Strong Buy Initiates $4 +393.22% Mar 27, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong Buy Maintains $9 +1,009.74% Mar 20, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.29
from -0.23
EPS Next Year
-0.44
from -0.29
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
---
Revenue Growth
-------
EPS
-0.23-0.10-0.17-0.23-0.29-0.44-0.59
EPS Growth
-------
Forward PE
-------
No. Analysts
----555
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202520262027
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -0.21 -0.42 -0.51
Avg -0.29 -0.44 -0.59
Low -0.41 -0.47 -0.67

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.